GlassScriptPhysician profile
April B Gentry
NPI 1447404488
$2,480.88
in general payments reported to CMS, 2019-2025
11 companies · $523 in 2025
The $523 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $836 · 2022: $422 · 2023: $575 · 2024: $126 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,223.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $735.35 | 2021-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $580.00 | 2021-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $305.86 | 2021-2022 | |
| Hologic Sales and Service, LLC | $290.99 | 2025 | Aptima |
| Abbott Laboratories | $157.93 | 2022-2023 | Freestyle Libre 3 |
| Insightec,INC | $124.46 | 2023 | Exablate |
| E.R. Squibb & Sons, L.L.C. | $124.32 | 2025 | Cobenfy |
| Lilly USA, LLC | $73.61 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $66.44 | 2023 | Spravato |
| Exact Sciences Corporation | $14.98 | 2024 | Cologuard Collection Kit |
| Genentech USA, INC. | $6.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Gentry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.